OncoTwin 2030: AI‑Driven Digital Twin Platform for Oncology Decision Support

OncoTwin 2030 is an advanced digital twin platform designed to enhance oncology decision‑making through multimodal data integration and AI‑driven clinical analytics. The system automatically extracts biomarkers from blood analyses, imaging studies and molecular profiles, generating a dynamic digital representation of each patient. This enables clinicians to assess radiotherapy eligibility, monitor treatment response, and identify risk factors with unprecedented precision.

The platform incorporates real‑time metric extraction, automated report generation, and a modular interface covering hematology, biomarkers, inflammation, hepatic/renal function, metabolism and additional clinical parameters. By combining medical data harmonisation, explainable AI and interoperable clinical workflows, OncoTwin 2030 supports personalised oncology, reduces diagnostic delays, and strengthens evidence‑based treatment decisions across healthcare settings.